Cereno Scientific develops therapies for cardiovascular diseases using epigenetic modulation and advances drug candidates like CS1.
Cereno Scientific has raised $37.0M in total funding. The most recent round was Post-IPO Debt. The last funding was announced in November 2025.
Cereno Scientific's investors include Arena Investors, Fenja Capital, GU Ventures, Venusat, SAJ Finans.
Cereno Scientific is headquartered in Mölndal, Sweden.
Cereno Scientific develops therapies for cardiovascular diseases using epigenetic modulation and advances drug candidates like CS1.
Cereno Scientific is at the Post-IPO Debt stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Cereno Scientific — Funding & Investors." VCBacked, November 28, 2025, https://www.vcbacked.co/company/cereno-scientific. Accessed August 15, 2026.
VCBacked. (2025). Cereno Scientific — Funding & Investors. Retrieved August 15, 2026, from https://www.vcbacked.co/company/cereno-scientific
{{cite web |title=Cereno Scientific — Funding & Investors |url=https://www.vcbacked.co/company/cereno-scientific |website=VCBacked |access-date=August 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated